Bioorganic Chemistry
FULL PAPER
enex Luna C18 column (250ꢃ4.6 mm, 5 m at 358C). The used solvent
system was 5 mm NH4OAC in water (A) and MeCN (B). The used gradi-
ent went from 0 to 100% B in 15 min. Reverse-phase HPLC: Agilent
1100 system equipped with a Phenomenex Luna C18 column (250ꢃ
4.6 mm, 5 m, at 508C) with 0.1m TEAA (containing 8% MeOH) and
MeOH as mobile phase (linear gradient: 0–30% MeOH in 15 min, 30–
100% MeOH in 3 min).
sequences of introducing cyclic or acyclic building blocks.
Rather than duplex stability, the precise orientation of the
modified building block seems to play an important role in
achieving selective cross-linking to one specific complemen-
tary base, as the observed localization of the furan moiety
coincides well with the observed cross-link selectivity. Fur-
thermore, calculations have illustrated the role of the phenyl
moiety in the bromination side reaction. The structural ex-
ploration conducted to date, with a gradually increasing
building block complexity, allows us to define some of the
parameters important for achieving acceptable yields and
cross-link selectivity.
In terms of a homogeneous diagnosis of a cytosine-related
one-point variation within DNA, the observed C selectivity
represents a remarkable advantage of cross-linking by cyclic
furan derivative 3. Whereas all previous furan-decorated
moieties in general form covalent bonds with A or C com-
plements, cyclic derivative 3 exhibits a rather pronounced
selectivity for cross-linking to one specific complementary
base. The method described herein constitutes one of the
few methodologies for site specific ICL formation in the
major groove. Furthermore, as indicated by enzymatic diges-
tion studies, cross-linking through 3 results in a less distorted
duplex, which possibly is an important factor for recognition
of cross-linked model duplexes by natural enzymes.
It can be concluded from the current work that restricted
mobility, though causing duplex destabilization, can have a
beneficial influence on the selectivity of the cross-link reac-
tion. Although the phenyl–furan moiety utilized here does
give rise to an undesired side reaction, a clear stabilizing in-
fluence on the duplex can be noted when comparing to the
acyclic furan-based system 1. Duplexes incorporating either
the building block 2 or 3 have been shown to be more
stable, in the range 5–158C, than the ones incorporating the
acyclic furan-containing counterpart.
In conclusion, the cyclic phenyl–furan-containing building
block shows a somewhat lower but still very appreciable iso-
lated yield of cross-linked duplex; however, its selectivity to-
wards cross-linking with C is considerably higher than in the
previous series. Given the modular nature of our building
block synthesis and the commercial availability of various
furan derivatives, the current study demonstrates that the
furan-oxidation cross-link strategy allows fine-tuning of se-
lectivity by the precise choice and conformational behavior
of the modified furan-containing moiety.
Synthesis of nucleoside building blocks
(S)-1-[Bis(4-methoxyphenyl)phenylmethoxy]-3-(4-furan-2-ylbenzyloxy)-
propan-2-ol (6): See Supporting Information for detailed procedures,
analysis data, and NMR spectra:
Diisopropylphosphoramidous acid 2-[bis(4-methoxyphenyl)methoxy]-1-
(4-furan-2-ylbenzyloxymethyl)ethyl ester 2-cyanoethyl ester (7): Com-
pound 6 (100 mg, 0.18 mmol) was dissolved in fresh distilled CH2Cl2
(6 mL) under argon atmosphere. N,N-Diisopropylammoniumtetrazolide
(46 mg, 0.27 mmol, 1.5 equiv) was added and the resulting mixture was
stirred at room temperature. 2-Cyanoethyltetraisopropylphosphoramidite
(60 mg, 0.2 mmol, 1.1 equiv) was added, while cooling on an ice-bath and
the reaction mixture was allowed to stir overnight at room temperature.
When no further conversion occurred, the reaction mixture was
quenched with MeOH (4 mL). The solvent was partially evaporated and
water was added. The product was extracted with CH2Cl2, dried on anhy-
drous Na2SO4, and the solvent was removed under reduced pressure. The
residue was purified using Merck silica gel (2:8 EtOAc/petroleum ether
with 1% Et3N) to yield 7 (106 mg, 79%) (Rf =0.32 (2:7 EtOAc/petrole-
um ether)). This product was used in the oligonucleotide synthesis. IR
(KBr-film): n˜ =2928, 1608, 1508, 1302, 1176, 829 cmÀ1; UV: lmax =285 nm
(H2O/ACN); LRMS (ESI-MS): m/z calcd for C44H51N2O7P: 750.3, found:
773.7 [M+Na]+; 31P NMR (121 MHz, CDCl3): d=149.44, 149.62 ppm.
2-[Bis-(4-methoxyphenyl)phenylmethoxymethyl]-5-(4-furan-2-ylphenyl)-
tetrahydrofuran-3-ol (11): See Supporting Information for detailed proce-
dures, analysis data and NMR spectra.
Diisopropylphosphoramidous acid 2-[bis-(4-methoxyphenyl)phenylmeth-
AHCTUNGTRENNUNG
(iPr2N)(NCCH2CH2O)PCl (95 mg, 0.4 mmol, 2.5 equiv) was added in one
portion and the resulting mixture was stirred at room temperature. After
2 h the reaction was quenched by addition of MeOH (2 mL), stirred for
another 15 min, followed by addition of saturated NaHCO3 solution
(3 mL). This mixture was extracted three times with CH2Cl2. The organic
layer was dried over Na2SO4 and evaporated under reduced pressure.
The reaction mixture was purified by column chromatography with 4:1
isooctane:EtOAc (1%TEA). The product was collected as a yellow oil
(70 mg, 0.091 mmol, 59%). Rf =0.30 (7:2 petroleum ether/EtOAc).
31P NMR (121 MHz, CDCl3): d=147.98, 148.16 ppm.
Materials and methods for oligonucleotides: Reagents for DNA synthesis
were obtained from Glen Research. All reverse-phase HPLC experi-
ments with oligonucleotides were recorded on an Agilent 1100 system
equipped with a Phenomenex Clarity column (250ꢃ4.6 mm, 5 m) at 508C
with 0.1m TEAA (with 5% MeCN) and MeCN as mobile phase (linear
gradient: 0–30% MeCN in 15 min). When stated the same conditions
were used with a Jupiter 300 ꢄ column (250ꢃ4.6 mm, 5 mm). The chro-
matograms were analyzed at 260 nm. Enzymatic digestion reaction mix-
tures were analyzed on a Phenomenex Luna C18 column (250ꢃ4.6 mm,
5 m) using the same method. HPLC-purified samples were subjected to
MALDI-TOF analysis. MALDI-TOF spectra were recorded in positive
mode on an Applied Biosystems voyager DE-STR biospectrometry
workstation. The matrix was a mixture of 0.7m 3-hydroxypicolinic acid
and 0.07m ammoniumcitrate for adduct suppression. The samples were
desalted by addition of small amounts DOWEX beads which were thor-
oughly rinsed with water before use. This was done in the sample tube
and not on the sample plate as in certain cases (if NaCNBH3 was pres-
ent) the sample plate corroded and presence of DOWEX beads resulted
in amorphous drying instead of crystallization.
Experimental Section
Materials and methods for chemical synthesis: All solvents and chemical
reagents were purchased from Sigma–Aldrich. 1H NMR and 13C NMR
spectra were recorded on a Bruker Avance 300 or a Bruker DRX 500
spectrometer operating at room temperature. Chemical shifts are report-
ed in parts per million (d) relative to the residual solvent peak. Multiplic-
ities are reported as singlet (s), doublet (d), doublet of doublets (dd),
triplet (t) or multiplet (m). Purities of small compounds were checked by
reverse-phase HPLC-MS or by reverse-phase HPLC. Reverse-phase
HPLC-MS: Agilent-1100 series LC/MS system equipped with a Phenom-
Synthesis of modified DNA: All oligonucleotides were synthesized
DMT-on using an ABI 394 DNA-synthesizer at 1 mmol scales. A standard
synthesis protocol was used except for coupling of the modified residues.
Chem. Eur. J. 2011, 17, 6940 – 6953
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6951